These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4369653)

  • 1. [Problems and treatment of recurrent herpes simplex].
    Fanta D; Kraft D; Söltz-Szöts J
    Z Hautkr; 1974 Jul; 49(14):597-606. PubMed ID: 4369653
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunotherapy of recurrent Herpes simplex diseases].
    Wassilew SW
    Hautarzt; 1979 Jun; 30(6):287-91. PubMed ID: 378899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of recurrent herpes simplex].
    Eichmann A
    Z Hautkr; 1977 Apr; 52(8):475-82. PubMed ID: 194427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific and unspecific immune stimulation in recurrent herpes simplex].
    Raab W
    Z Hautkr; 1977 May; 52(10):565-72. PubMed ID: 195407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with inactivated polyvalent herpes vaccines.
    Dundarov S; Andonov P; Bakalov B; Nechev K; Tomov C
    Dev Biol Stand; 1982; 52():351-8. PubMed ID: 6299844
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent herpes genitalis. Treatment with Mycobacterium bovis (BCG).
    Anderson FD; Ushijima RN; Larson CL
    Obstet Gynecol; 1974 Jun; 43(6):797-805. PubMed ID: 4364209
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of antibody in in vitro stimulation of lymphocytes.
    Kapoor AK; Khan IU; Bhushan V
    Indian J Exp Biol; 1983 Nov; 21(11):583-4. PubMed ID: 6327508
    [No Abstract]   [Full Text] [Related]  

  • 8. [Status of antiviral immunity in patients with recurrent herpes].
    Semenova TB; Posevaia TA; Karpovich LG; Bukovskaia SN; Blokha VV
    Vestn Dermatol Venerol; 1987; (6):43-7. PubMed ID: 2820161
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical aspects and importance of human herpex simplex infections. Results of herpes antigen therapy].
    Wassilew SW; Nasemann T
    MMW Munch Med Wochenschr; 1980 Jan; 122(1):25-7. PubMed ID: 6245350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indices of the immune status of recurrent herpes patients being treated with a herpes polyvaccine].
    Belokrinitskiĭ DV; Karpovich LG; Barinskiĭ IF; Bukovskaia SN; Semenova TB
    Vopr Virusol; 1987; 32(2):229-33. PubMed ID: 3037800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus vaccines.
    Wise TG; Pavan PR; Ennis FA
    J Infect Dis; 1977 Nov; 136(5):706-11. PubMed ID: 199677
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of protective mechanism against herpes simplex virus (HSV) infection in mice (author's transl)].
    Nagafuchi S
    Fukuoka Igaku Zasshi; 1980 Jul; 71(7):353-64. PubMed ID: 6260612
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recurrent herpes catarrhalis].
    Shakhtmeĭster IIa
    Med Sestra; 1984 Oct; 43(10):23-5. PubMed ID: 6084162
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of recurrent infection by Herpesvirus hominis.
    Bierman SM
    Arch Dermatol; 1976 Oct; 112(10):1459-61. PubMed ID: 183607
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antigen therapy of recurring herpes simplex with herpes simplex vaccine LUPIDON H and G].
    Schneider J; Rohde B
    Z Haut Geschlechtskr; 1972 Dec; 47(24):973-80. PubMed ID: 4346378
    [No Abstract]   [Full Text] [Related]  

  • 17. [Infections due to herpes simplex virus, recurrent disease and problem of latency].
    Terni M
    G Mal Infett Parassit; 1971 Jul; 23(7):433-67. PubMed ID: 4334706
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
    Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
    J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of recurrent Herpes simplex].
    Söltz-Szöts J
    Z Haut Geschlechtskr; 1971 Apr; 46(8):267-72. PubMed ID: 4324186
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinico-immunological aspects of recurrent herpes simplex during vaccine therapy].
    Semenova TB; Karpovich LG; Barinskiĭ IF; Blokha VV; Kalashnikova TV
    Vestn Dermatol Venerol; 1988; (7):49-53. PubMed ID: 2851233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.